Find Federal Grants
Ending the HIV/HCV/Syphilis Epidemics in Indian Country II (ETHIC II): A Syndemic Elimination Program for American Indian and Alaska Native Tribes and Urban Indian Communities
Indian Health Service · HHS-2024-IHS-ETHIC-0001
Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-24-029
U.S. Mission to Gabon · LIBREVILLE-SSH01-2024
Health Resources and Services Administration · HRSA-24-082
Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)
National Institutes of Health · RFA-MD-24-009
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
National Institutes of Health · PAR-24-239
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
National Institutes of Health · PAR-24-238
Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
Centers for Disease Control - NCCDPHP · CDC-RFA-DP-25-0016
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-MH-25-181
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-MH-25-180
National Institutes of Health · PAR-24-204
Office of the National Coordinator · NAP-AX-24-001
Nurse Education, Practice, Quality and Retention (NEPQR) - Workforce Expansion Program (WEP)
Health Resources and Services Administration · HRSA-24-098
Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clinical Trial Optional)
National Institutes of Health · RFA-MH-25-136
Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)
National Institutes of Health · RFA-MH-25-135
Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-25-050
Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-25-049
Senegal USAID-Dakar · 72068524RFA00016
Research Collaboration Network in Structural Racism Measurement and Modeling (U24 Clinical Trial Optional)
National Institutes of Health · RFA-AG-25-003
Rural Business-Cooperative Service · RDBCP-DHCS-2024